IMRT features in £21m round of Scottish radiotherapy capacity and upgrade programme
This article was originally published in Clinica
Executive Summary
Scotland is investing almost £21m ($30m) in radiotherapy equipment over the next year, in a bid to ensure its five cancer centres are "at the cutting edge" of the technology. This year's round of the Radiotherapy Equipment Programme (REP) features intensity-modulated radiation therapy (IMRT) units to provide "high-precision radiotherapy" using computer-controlled X-ray accelerators (Linacs) to precisely target the tumour, or specific areas of it. The approval of the REP's 2009-10 capacity and upgrade investment was announced by Scottish health secretary Nicola Sturgeon today at Edinburgh's Western General hospital, which has received brachytherapy equipment and Linacs through the REP.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.